Hydrogen sulfide production does not affect antibiotic resistance in .

Hydrogen sulfide (HS) has been proposed to protect bacteria from antibiotics, pointing to HS-producing enzymes as possible targets for the development of antibiotic adjuvants. Here, MIC assays performed with mutants producing altered HS levels demonstrate that HS does not affect antibiotic resistance in this bacterium. Moreover, correlation analyses in a large collection of cystic fibrosis isolates argue against the protective role of HS from antibiotic activity during chronic lung infection.